AWMF
The AWMF – the Association of the Scientific Medical Societies in Germany – is a kind of umbrella organization for medical societies in Germany. It was founded in 1962 and today brings together over 170 scientific organizations that deal with various areas of medicine. Its aim is to promote medical science, network experts and bring findings into practice. One of these specialist societies is the DGKL, the German Society for Clinical Chemistry and Laboratory Medicine. It deals with everything to do with laboratory analyses and diagnostics. Cooperation between the AWMF and DGKL plays an important role – especially when it comes to patient safety.
What does the AWMF do?
The AWMF is like a coordinator in the background. It ensures that the various medical specialties do not work in isolation, but exchange information and set standards together. The AWMF is particularly well known for its work on guidelines. These are recommendations that help doctors and other specialists to make the best decisions on diagnoses and treatments. These guidelines are based on scientific findings and are intended to ensure that patients receive the same quality of care throughout Germany. The AWMF also represents the interests of the specialist societies to politicians and the public and promotes projects that improve the quality of healthcare.
What role does the DGKL play?
The DGKL is one of the member societies of the AWMF and focuses on laboratory medicine. This means that it deals with blood tests, urinalysis and other examinations that are carried out in laboratories. These tests are crucial for detecting diseases such as diabetes, infections or cancer. The DGKL is committed to ensuring that such analyses are reliable and accurate. It not only issues its own recommendations, but also works on quality assurance – for example through so-called interlaboratory comparisons, in which laboratories compare their results in order to avoid errors.
How do the AWMF and DGKL work together?
The collaboration between the AWMF and DGKL is a good example of how different levels of medicine can work hand in hand. The AWMF provides a platform on which the DGKL can contribute its expertise. For example, the DGKL is involved in the development of guidelines that also cover aspects of laboratory medicine. During the coronavirus pandemic, for example, the DGKL was part of an AWMF task force that developed recommendations for testing and dealing with the crisis. Such guidelines help to ensure that laboratories work in a standardized and safe manner – regardless of whether PCR tests or other diagnoses are involved.
Another area of cooperation is quality assurance. The DGKL contributes its knowledge of laboratory standards, while the AWMF ensures that these standards are embedded in overarching concepts. This results in rules that apply not only to laboratories, but to the entire healthcare system. The AWMF also supports the DGKL in making its concerns visible and vice versa – for example by commenting on legislative changes, such as the testing ordinance during the pandemic.
Why is this important for patient safety?
The work of the AWMF and DGKL has a direct impact on patients. Imagine a blood test falsely indicating that someone is healthy even though they have a serious illness. Such errors can be devastating. The DGKL uses its expertise to ensure that laboratory tests are reliable – for example through standards for equipment and methods. The AWMF, in turn, ensures that these standards are not only applied in laboratory medicine, but also in practice by doctors. Guidelines, in which the DGKL is involved, provide clear specifications: Which tests are useful and when? How should results be interpreted? This reduces risks and increases the chance of diseases being detected early and treated correctly.
One specific example is the coronavirus pandemic. The DGKL helped to develop test strategies, which the AWMF then disseminated widely. This ensured that only high-quality tests were used and that the results were reliable – a crucial contribution to containing infections and protecting vulnerable people.
Conclusion
The AWMF and the DGKL complement each other perfectly: the AWMF thinks big and is networked, while the DGKL contributes its expertise in laboratory medicine. Together, they create standards that increase the quality of diagnostics and minimize errors. For patients, this means greater safety – whether through precise tests or well-coordinated treatment paths. At a time when medicine is becoming increasingly complex, this collaboration is key to ensuring trust and protection.
Matching:
AWMF presents concept for maintaining the National Care Guidelines – MedLabPortal
Editorial office: X-Press Journalistenbüro GbR
Gender note. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple references and gendered designations are avoided for the sake of better readability ected.
